Defining nonmedical use of prescription opioids within health care claims: A systematic review

Substance Abuse

Volumn 36, Issue 2, 2015, Pages 192-202

  Cochran, Gerald ^a   Woo, Bongki ^b   Lo Ciganic, Wei Hsuan ^a   Gordon, Adam J ^a,c,d   Donohue, Julie M ^a,e   Gellad, Walid F ^a,c,d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b BOSTON COLLEGE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

health insurance; Non medical use of prescription opioids; systematic review

Indexed keywords

NARCOTIC ANALGESIC AGENT;

HEALTH INSURANCE; HUMAN; INSURANCE; NOMENCLATURE; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS;

ANALGESICS, OPIOID; HUMANS; INSURANCE BENEFITS; INSURANCE, HEALTH; SUBSTANCE-RELATED DISORDERS; TERMINOLOGY AS TOPIC;

EID: 84931577586     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1080/08897077.2014.993491     Document Type: Article

References (39)

1. Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report. Vital Signs: Overdoses of Prescription Opioid Pain Relievers-United States, 1999-2008. Atlanta, GA: Centers for Disease Control and Prevention; 2011.
2. Manchikanti L, Singh A. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedicaluse ofopioids.PainPhysician.2008;11(2Suppl):S63-S88.
3. Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician. 2010;12:401-435.
4. Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013.
5. Paulozzi LJ, Kilbourne EM, Desai HA. Prescription drug monitoring programs and death rates from drug overdose. Pain Med. 2011;12:747-754.
6. Hahn KL. Strategies to prevent opioid misuse, abuse, and diversion that may also reduce the associated costs. Am Health Drug Benefits. 2011;4:107-113.
7. American Academy of Family Physicians. FDA approves labeling for reformulated, abuse-deterrent version of oxycontin. Am Fam Physician. 2013;87:730.
8. Huang B, Dawson DA, Stinson FS, et al. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: results of the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006;67:1062-1073.
9. Becker WC, Sullivan LE, Tetrault JM, Desai RA, Fiellin DA. Nonmedical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates. Drug Alcohol Depend. 2008;94:38-47.
10. White AG, Birnbaum HG, Schiller M, Tang J, Katz NP. Analytic models to identify patients at risk for prescription opioid abuse. Am J Manag Care. 2009;15:897-906.
11. Martins SS, Keyes KM, Storr CL, Zhu H, Chilcoat HD. Pathways between nonmedical opioid use/dependence and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2009;103:16-24.
12. Novak SP, Herman-Stahl M, Flannery B, Zimmerman M. Physical pain, common psychiatric and substance use disorders, and the nonmedical use of prescription analgesics in the United States. Drug Alcohol Depend. 2009;100:63-70.
13. Rice JB, White AG, Birnbaum HG, Schiller M, Brown DA, Roland CL. A model to identify patients at risk for prescription opioid abuse, dependence, and misuse. Pain Med. 2012;13:1162-1173.
14. Unick GJ, Rosenblum D, Mars S, Ciccarone D. Intertwined epidemics: national demographic trends in hospitalizations for heroin-and opioid-related overdoses, 1993-2009. PloS ONE. 2013;8:e54496.
15. Sullivan MD, Edlund MJ, Zhang L, Unutzer J, Wells KB. Association between mental health disorders, problem drug use, and regular prescription opioid use. Archives of Internal Medicine. 2006;166: 2087-2093.
16. Amari E, Rehm J, Goldner E, Fischer B. Nonmedical prescription opioid use and mental health and pain comorbidities: a narrative review. Can J Psychiatry. 2011;56:495-502.
17. Hudson TJ, Edlund MJ, Steffick DE, Tripathi SP, SullivanMD. Epidemiology of regular prescribed opioid use: results from a national, population-based survey. J Pain Symptom Manage. 2008;36:280-288.
18. Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA. 2013;309:657-659.
19. Birnbaum HG, White AG, Schiller M, Waldman T, Cleveland JM, Roland CL. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med. 2011;12:657-667.
20. Biondo G, Chilcoat HD. Discrepancies in prevalence estimates in two national surveys for nonmedical use of a specific opioid product versus any prescription pain reliever. Drug Alcohol Depend. 2014;134:396-400.
21. National Institute on Drug Abuse. Prescription Drug Abuse. What is prescription drug abuse? Available at: http://www.drugabuse.gov/publications/research-reports/prescription-drugs/what-prescriptiondrug-abuse. Published 2011. Accessed April 25, 2014.
22. LeBaron P, Dean E. 2012 National Survey on Drug Use and Health: CAI Specifications for Programming. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2011.
23. Kessler RC, Abelson J, Demler O, et al. Clinical calibration of DSMIV diagnoses in the World Mental Health version of the World Health Organization Composite International Diagnostic Interview. Int J Methods Psychiatr Res. 2004;13:122-139.
24. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Geneva: World Health Organization; 2009.
25. Substance Abuse and Mental Health Services Administration. Overview of Findings from the 2003 National Survey on Drug Use and Health. Rockville, MD: SAMHSA, Office of Applied Studies; 2004. NSDUH Series H-24, DHHS Publication No. SMA 04-3963.
26. National Institute on Drug Abuse. Research Report Series, Prescription Drugs: Abuse and Addiction. Bethesda, MD: National Institute on Drug Abuse; 2011.
27. Braker LS, Reese AE, Card RO, Van Howe RS. Screening for potential prescription opioid misuse in a michigan medicaid population. Family Med. 2009;41:729.
28. Leider HL, Dhaliwal J, Davis EJ, Kulakodlu M, Buikema AR. Healthcare costs and nonadherence among chronic opioid users. Am J Manag Care. 2011;17:32-40.
29. Logan J, Liu Y, Paulozzi L, Zhang K, Jones C. Opioid prescribing in emergency departments: the prevalence of potentially inappropriate prescribing and misuse. Med Care. 2013;51:646-653.
30. Roland CL, Joshi AV, Mardekian J, Walden SC, Harnett J. Prevalence and cost of diagnosed opioid abuse in a privately insured population in the United States. J Opioid Manag. 2013;9:161-175.
31. Sullivan MD, Edlund MJ, Fan M-Y, DeVries A, Braden JB, Martin BC. Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and Medicaid insurance plans: The TROUP Study. Pain. 2010;150:332-339.
32. Knisely JS, Wunsch MJ, Cropsey KL, Campbell ED. Prescription Opioid Misuse Index: a brief questionnaire to assess misuse. J Subst Abuse Treat. 2008;35:380-386.
33. Butler SF, Budman SH, Fernandez KC, et al. Development and validationof theCurrentOpioidMisuseMeasure.Pain.2007;130:144-156.
34. CepedaMS, FifeD, ChowW, MastrogiovanniG, HendersonSC.Assessing opioid shopping behaviour: a large cohort study from a medication dispensingdatabase in theUS.DrugSaf.2012;35:325-334.
35. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentionalpharmaceuticaloverdose fatalities.JAMA.2008;300:2613-2620.
36. Baumblatt J, Wiedeman C, Dunn JR, Schaffner W, Paulozzi LJ, Jones TF. High-risk use by patients prescribed opioids for pain and its role in overdose deaths. JAMA Intern Med. 2014;174:796-801.
37. Smith SM, Dart RC, Katz NP, et al. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain. 2013;154:2287-2296.
38. American College of Preventive Medicine. Use, abuse, misuse and disposal of prescription pain medication clinical reference. Available at: http://www.acpm.org/?UseAbuseRxClinRef. Published 2011. Accessed April 4, 2014.
39. MedlinePlus. Prescription drug abuse. Available at: http://www.nlm. nih.gov/medlineplus/prescriptiondrugabuse.html. Published 2014. Accessed April 4, 2014.